Ultrasound‐Guided Platelet Rich Plasma (PRP) Injections for Greater Trochanteric Pain Syndrome (GTPS): A Retrospective Case Series

Massimi, Stephen; LaSalle, Elizabeth E.; Vongvorachoti, Joe; Lutz, Gregory E.

doi:10.1016/j.pmrj.2013.08.298

Cited by 3 publications

(4 citation statements)

References 0 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…In total, five studies were included for analysis consisting of three RCTs [ 28–30 ] and two case series [ 31 , 32 ]. We also identified four additional studies from published conference abstracts (one RCT [ 34 ] and three case series [ 33 , 35 , 36 ]).…”

Section: Resultsmentioning

confidence: 99%

“…LaSalle et al ’s [ 36 ] abstract retrospectively reported the efficacy of US-guided PRP injections in patients with radiologically (MRI) proven gluteus medius or minimus tears, tendinosis or degeneration. Ten patients had more than 12 weeks unsuccessful conservative treatment.…”

Section: Conference Abstracts Resultsmentioning

confidence: 99%

“…Although the study was randomized with a modest sample size compared with other reviewed articles, without a full-text article the randomization process and study design could not be evaluated. The main limitation shared by the non-randomized studies outside of being non-peer reviewed were a lack of a control group [ 33 , 35 , 36 ]. Blucher et al ’s [ 33 ] study strengths include a large sample size and prospectively collected data.…”

Section: Discussionmentioning

confidence: 99%

“…Furthermore, as GTPS may have been secondary to surgery or distortion of biomechanics, the judgement on the efficacy in this study might not be accurate, therefore conclusions are difficult to draw from this article. Lasalle et al ’s study was limited by a small sample size of 10 patients [ 36 ].…”

Section: Discussionmentioning

confidence: 99%

See 3 more Smart Citations

The use of platelet-rich plasma in the treatment of greater trochanteric pain syndrome: a systematic literature review

Ali

Oderuth

Atchia

et al. 2018

Journal of Hip Preservation Surgery

View full text Add to dashboard Cite

This review aims to determine whether platelet-rich plasma (PRP) has any role in improving clinical outcomes in patients with symptomatic greater trochanteric pain syndrome (GTPS). A search of NICE healthcare database advanced search (HDAS) via Athens (PubMed, MEDLINE, CINAHL, EMBASE and AMED databases) was conducted from their year of inception to April 2018 with the keywords: ‘greater trochanteric pain syndrome’ or ‘GTPS’ or ‘gluteus medius’ or ‘trochanteric bursitis’ and ‘platelet rich plasma’ (PRP). A quality assessment was performed using the JADAD score for RCTs and MINORS for non-RCT studies. Five full-text articles were included for analysis consisting of three RCTs and two case series. We also identified four additional studies from published conference abstracts (one RCT and three case series). The mean age in 209 patients was 58.4 years (range 48–76.2 years). The majority of patients were females and the minimum duration of symptoms was three months. Diagnosis was made using ultrasound or MRI. Included studies used a variety of outcome measures. Improvement was observed during the first 3 months after injection. Significant improvement was also noted when patients were followed up till 12 months post treatment. PRP seems a viable alternative injectable option for GTPS refractory to conservative measures. The current literature has revealed that PRP is relatively safe and can be effective. Considering the limitations in these studies, more large-sample and high-quality randomized clinical trials are required in the future to provide further evidence of the efficacy for PRP as a treatment in GTPS.Systematic Review RegistrationPROSPERO CRD42017080662Level of EvidenceLevel I, systematic review of Level I studies.

show abstract